- Home
- EVRG vs LH Comparison
EVRG vs LH Comparison
Compare EVRG & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVRG | LH |
|---|---|---|
| Founded | 2017 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Power Generation | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 21.7B |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | EVRG | LH |
|---|---|---|
| Price | $82.96 | $257.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $87.38 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 1.4M | 578.3K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.42% | 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | 3.66 | ★ 10.46 |
| Revenue | $5,961,600,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | $6.52 | $8.26 |
| Revenue Next Year | $7.12 | $4.81 |
| P/E Ratio | ★ $22.66 | $24.44 |
| Revenue Growth | 1.95 | ★ 7.25 |
| 52 Week Low | $64.75 | $239.75 |
| 52 Week High | $85.27 | $293.72 |
Technical Indicators
Market Signals| Indicator | EVRG | LH |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 35.84 |
| Support Level | $75.04 | $246.08 |
| Resistance Level | $83.53 | $275.06 |
| Average True Range (ATR) | 1.34 | 7.20 |
| MACD | 0.06 | -1.34 |
| Stochastic Oscillator | 72.34 | 11.56 |
Price Performance
Historical ComparisonAbout EVRG Evergy Inc.
Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission. The utility has a combined rate base of more than $20 billion, about half in Kansas and the rest split between Missouri and interstate transmission. Evergy is one of the largest wind energy suppliers in the US.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.